Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
- PMID: 22684094
- PMCID: PMC3505864
- DOI: 10.1136/thoraxjnl-2011-201518
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Abstract
Background: The long-term natural history of chronic obstructive pulmonary disease (COPD) in terms of successive severe exacerbations and mortality is unknown.
Methods: The authors formed an inception cohort of patients from their first ever hospitalisation for COPD during 1990-2005, using the healthcare databases from the province of Quebec, Canada. Patients were followed until death or 31 March 2007, and all COPD hospitalisations occurring during follow-up were identified. The hazard functions of successive hospitalised COPD exacerbations and all-cause mortality over time were estimated, and HRs adjusted for age, sex, calendar time and comorbidity.
Results: The cohort included 73 106 patients hospitalised for the first time for COPD, of whom 50 580 died during the 17-year follow-up, with 50% and 75% mortality at 3.6 and 7.7 years respectively. The median time from the first to the second hospitalised exacerbation was around 5 years and decreased to <4 months from the 9th to the 10th. The risk of the subsequent severe exacerbation was increased threefold after the second severe exacerbation and 24-fold after the 10th, relative to the first. Mortality after a severe exacerbation peaked to 40 deaths per 10 000 per day in the first week after admission, dropping gradually to 5 after 3 months.
Conclusions: The course of COPD involves a rapid decline in health status after the second severe exacerbation and high mortality in the weeks following every severe exacerbation. Two strategic targets for COPD management should include delaying the second severe exacerbation and improving treatment of severe exacerbations to reduce their excessive early mortality.
Conflict of interest statement
Figures





Comment in
-
β-blockers for COPD inpatients.Thorax. 2012 Nov;67(11):936-7. doi: 10.1136/thoraxjnl-2012-202471. Thorax. 2012. PMID: 23100217 No abstract available.
-
[New strategies are needed for treatment of COPD].Dtsch Med Wochenschr. 2013 Jan;138(4):112. Dtsch Med Wochenschr. 2013. PMID: 23441340 German. No abstract available.
-
Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality.Expert Rev Pharmacoecon Outcomes Res. 2013 Apr;13(2):187-9. doi: 10.1586/erp.13.9. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 23570429
References
-
- Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532–55 - PubMed
-
- Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397–412 - PubMed
-
- Minino AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. National Vital Statistics Reports NCHS. 2010;59(2). http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical